Parapelvic Renal Cyst Treatment with Flexible Ureteroscopy: Single Centre Experience
Archivos Espanoles de Urologia, cilt.77, sa.4, ss.331-337, 2024 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 77 Sayı: 4
- Basım Tarihi: 2024
- Doi Numarası: 10.56434/j.arch.esp.urol.20247704.45
- Dergi Adı: Archivos Espanoles de Urologia
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.331-337
- Anahtar Kelimeler: parapelvic cyst, ureteroscopy, endoscopy, laser treatment
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: This study aimed to assess the feasibility, safety, and efficacy of an endoscopic parapelvic renal cyst (PRC) incision using flexible ureterorenoscopy (fURS). Material and Methods: We retrospectively reviewed data concerning 16 patients in whom PRC incisions had been performed using fURS between January 2016 and January 2022. Two patients were excluded from the study owing to a lack of follow-up information. The cysts of all the patients were evaluated preoperatively by computed tomography. The patients’ age, gender, cyst size, presenting symptoms, postoperative complications, and pre- and post-treatment visual analogue scale (VAS) scores were evaluated. Surgical success was defined as a reduction of more than half of the cyst size in the sixth postoperative month. Results: A total of 14 patients were included in this study. The patients’ mean age was 52.6 ± 8.8 years, and the mean cyst size was 69.1 ± 15.5 mm. Twelve (85.7%) patients presented with flank pain. Clavien–Dindo grade 1 complications were observed in two patients (14.3%), and grade 2 complications were observed in one (7.1%). The median VAS scores were significantly lower after treatment than before in patients who presented with flank pain (2 (1–2.8) vs 8 (7–8), respectively; p = 0.002). Surgical success rate was detected in 11 patients (78.6%) six months after the treatment. Conclusions: Endoscopic incision of the PRC is a feasible treatment modality with high success rates and low complication rates. However, multicentre studies with larger populations and longer follow-ups are needed to evaluate the lasting effects.